Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
11
×
startups
11
×
national blog main
life sciences
deals
medical devices
vc
detroit blog main
national top stories
new york blog main
san diego blog main
san francisco blog main
seattle blog main
tech
aphelion capital
boston blog main
boston top stories
detroit
detroit top stories
diabetes
diagnostics
dna
entrepreneurship
funding
health
healthcare
innovation
medical device
medtech
oncology
precision medicine
san diego
san diego top stories
san francisco top stories
seattle
seattle top stories
wisconsin blog main
30ventures
acquisition
alivecor
What
based
11
×
startup
medical
million
developing
raised
week
company
diagnostics
ann
arbor
biotech
capital
develop
diabetes
fund
including
make
new
plans
raise
research
seattle
series
step
technologies
venture
ventures
additions
adds
advance
aims
alison
amogha
analysis
announced
approach
arrhythmia
associates
attention
Language
unset
unknown
Current search:
startups
×
based
×
biotech
×
@techcrunch.com
1 year ago
Nanopath is looking to drastically change medical diagnostics
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Spine-Surgery Medtech Startup Carlsmed Merges With Imaging Company
@xconomy.com
5 years ago
Bardy Diagnostics to Ramp Up Cardiac Monitor Sales With $35M Raise
@xconomy.com
5 years ago
Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch
@xconomy.com
5 years ago
Magnolia Medical Captures $20M to Reduce Blood Culture Contamination
@xconomy.com
5 years ago
Celsee Charts Expansion Plans as Single-Cell Analysis Demand Grows
@xconomy.com
5 years ago
30Ventures Seeks $15M to Fund Startups in Healthcare, Water Tech
@xconomy.com
5 years ago
Pfizer, Merck Lead Strata Oncology’s $26M Series B Round
@techcrunch.com
6 years ago
Fractyl Labs raises $44 million in Series D to develop a treatment for type 2 diabetes